T TG THERAPEUTICS INC
| Market Cap | $4.58B |
| P/E Ratio | 10.36 |
| Forward P/E | 11.50 |
| Dividend Yield | — |
| Beta | 1.86 |
| 52W Range | $25.28 - $46.48 |
| # Hedge Funds | 0 |
| Sector | Healthcare |
| Industry | Biotechnology |
Hedge Fund Ownership
| Investor 0 | % of Portfolio Weight of this stock in the investor's portfolio | Value Total dollar value of the position | Shares Number of shares held | Activity Portfolio change type: New, Increased, Decreased, or Sold |
|---|
Insider Trading
| Insider Name of the company insider who made the trade 2 | Type Purchase (buy) or Sale (sell) | Shares Number of shares traded | Price Price per share at time of transaction | Value Total dollar value of the transaction | Trade Date Date the transaction was executed | Filing Date Date the SEC filing was submitted |
|---|---|---|---|---|---|---|
| Echelard Yann | Sale | 5,000 | $32.57 | $162.85K | 24 Nov 2025 | 25 Nov 2025 |
| Yann EchelardDirector | Sale | 5,000 | $32.57 | $162.85K | 24 Nov 2025 | 25 Nov 2025 |
Frequently Asked Questions
What is TGTX stock price today?
TG THERAPEUTICS INC (TGTX) is currently trading at $28.70. The stock has a 52-week range of $25.28 to $46.48 and a market capitalization of $4.58B.
Is TGTX a good stock to buy in 2026?
TG THERAPEUTICS INC has a P/E ratio of 10.4 (forward P/E: 11.5), a dividend yield of none, and 1-year performance of -26.9%. 0 hedge funds hold this stock. Review the fundamentals and ownership data above to make an informed decision.
Are insiders buying or selling TGTX stock?
There have been 2 insider transactions for TGTX in recent months. Insider buys can signal management confidence, while sales may reflect diversification or personal financial planning. Check the Insider Trading section above for details.
How has TGTX stock performed over the past year?
TG THERAPEUTICS INC (TGTX) has returned -26.9% over the past 12 months. The stock traded between $25.28 and $46.48 during this period, and is currently at $28.70.
Which hedge funds own TGTX (TG THERAPEUTICS INC)?
0 tracked hedge funds currently hold TGTX in their portfolios as of the latest 13F filings. See the ownership table above for the complete list.
What is TGTX's market cap and valuation?
TG THERAPEUTICS INC (TGTX) has a market capitalization of $4.58B. The trailing P/E ratio is 10.4 and forward P/E is 11.5. The stock is classified in the Healthcare sector.
What is TGTX's revenue and profitability?
TG THERAPEUTICS INC reported revenue of $616.29M with net income of $447.18M and a profit margin of 0.73%. The stock has a beta of 1.86.
What sector is TGTX in and who are its biggest institutional holders?
TG THERAPEUTICS INC (TGTX) operates in the Healthcare sector. It is held by 0 tracked hedge funds. See the ownership table above for the complete list.